{"entity":{"id":"jnci","kind":"journal","name":"JNCI: Journal of the National Cancer Institute","aka":["JNCI","J Natl Cancer Inst","src-jnci"],"tldr":"JNCI began as the US National Cancer Institute's own journal and is now independent. It is strong on cancer epidemiology, screening, trial methodology and health disparities.","summary":"Founded in 1940 as the NCI's journal and now published by Oxford University Press with an independent editorial board. Publishes epidemiology and risk-factor studies, screening and surveillance research, trial-methods and trial-participation analyses (Unger's 2019 review of barriers to trial enrolment in this corpus), and the annual US 'Report to the Nation' on cancer status. Hybrid access.","asOf":"2026-09-09","links":[{"label":"JNCI Cancer Spectrum (open access sister)","url":"https://academic.oup.com/jncics"}],"tags":[],"related":["jnci-cancer-spectrum","jnci-monographs"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["nci"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Holds: Epidemiology, screening, health policy and trials. Access: Paywalled; some open access."],"publisher":"Oxford University Press","url":"https://academic.oup.com/jnci","issn":"0027-8874","scope":"cancer epidemiology","access":"hybrid","founded":1940,"matchNames":["JNCI: Journal of the National Cancer Institute","Journal of the National Cancer Institute","JNCI","J Natl Cancer Inst"]},"route":"/journals/jnci/","neighbours":{"journal":[{"id":"jnci-cancer-spectrum","kind":"journal","name":"JNCI cancer spectrum","route":"/journals/jnci-cancer-spectrum/"},{"id":"jnci-monographs","kind":"journal","name":"Journal of the National Cancer Institute. Monographs","route":"/journals/jnci-monographs/"}],"institution":[{"id":"nci","kind":"institution","name":"National Cancer Institute (NIH)","route":"/institutions/nci/"}],"paper":[{"id":"paper-montgomery-j-natl-cancer-inst","kind":"paper","name":"A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients","route":"/key-papers/paper-montgomery-j-natl-cancer-inst/"},{"id":"paper-hu-j-natl-cancer-inst","kind":"paper","name":"An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening","route":"/key-papers/paper-hu-j-natl-cancer-inst/"},{"id":"paper-johnson-j-natl-cancer-inst","kind":"paper","name":"Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report","route":"/key-papers/paper-johnson-j-natl-cancer-inst/"},{"id":"paper-lu-j-natl-cancer-inst","kind":"paper","name":"Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial","route":"/key-papers/paper-lu-j-natl-cancer-inst/"},{"id":"paper-siegel-colorectal-incidence-birth-cohort-jnci-2017","kind":"paper","name":"Colorectal cancer incidence patterns in the United States, 1974-2013","route":"/key-papers/paper-siegel-colorectal-incidence-birth-cohort-jnci-2017/"},{"id":"paper-wyatt-ctdna-tissue-concordance-mcrpc-jnci-2017","kind":"paper","name":"Concordance of circulating tumour DNA and matched metastatic tissue biopsy in prostate cancer","route":"/key-papers/paper-wyatt-ctdna-tissue-concordance-mcrpc-jnci-2017/"},{"id":"paper-mcneil-j-natl-cancer-inst","kind":"paper","name":"Effect of Aspirin on Cancer Incidence and Mortality in Older Adults","route":"/key-papers/paper-mcneil-j-natl-cancer-inst/"},{"id":"paper-shastri-j-natl-cancer-inst","kind":"paper","name":"Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India","route":"/key-papers/paper-shastri-j-natl-cancer-inst/"},{"id":"paper-hanai-j-natl-cancer-inst","kind":"paper","name":"Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial","route":"/key-papers/paper-hanai-j-natl-cancer-inst/"},{"id":"paper-mathijssen-j-natl-cancer-inst","kind":"paper","name":"Effects of St. John's wort on irinotecan metabolism","route":"/key-papers/paper-mathijssen-j-natl-cancer-inst/"},{"id":"paper-eortc-24891-larynx-preservation-lefebvre-jnci-1996","kind":"paper","name":"EORTC 24891: larynx preservation with induction chemotherapy in pyriform sinus (hypopharyngeal) cancer","route":"/key-papers/paper-eortc-24891-larynx-preservation-lefebvre-jnci-1996/"},{"id":"paper-foulkes-brca1-basal-phenotype-jnci-2003","kind":"paper","name":"Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer","route":"/key-papers/paper-foulkes-brca1-basal-phenotype-jnci-2003/"},{"id":"paper-draisma-lead-time-overdiagnosis-psa-jnci-2009","kind":"paper","name":"Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context","route":"/key-papers/paper-draisma-lead-time-overdiagnosis-psa-jnci-2009/"},{"id":"paper-welch-j-natl-cancer-inst","kind":"paper","name":"Overdiagnosis in cancer","route":"/key-papers/paper-welch-j-natl-cancer-inst/"},{"id":"paper-rugo-pd-l1-assay-comparison-impassion130-jnci-2021","kind":"paper","name":"PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer","route":"/key-papers/paper-rugo-pd-l1-assay-comparison-impassion130-jnci-2021/"},{"id":"paper-luca-gianni-j-natl-cancer-inst-2022","kind":"paper","name":"Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab","route":"/key-papers/paper-luca-gianni-j-natl-cancer-inst-2022/"},{"id":"paper-church-pole-endometrial-jnci-2015","kind":"paper","name":"Prognostic significance of POLE proofreading mutations in endometrial cancer","route":"/key-papers/paper-church-pole-endometrial-jnci-2015/"},{"id":"paper-lowery-prospective-germline-exocrine-pancreatic-jnci-2018","kind":"paper","name":"Prospective evaluation of germline alterations in patients with exocrine pancreatic neoplasms","route":"/key-papers/paper-lowery-prospective-germline-exocrine-pancreatic-jnci-2018/"},{"id":"paper-welch-albertsen-psa-era-diagnosis-treatment-jnci-2009","kind":"paper","name":"Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening, 1986 to 2005","route":"/key-papers/paper-welch-albertsen-psa-era-diagnosis-treatment-jnci-2009/"},{"id":"paper-shimelis-tnbc-risk-genes-jnci-2018","kind":"paper","name":"Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing","route":"/key-papers/paper-shimelis-tnbc-risk-genes-jnci-2018/"},{"id":"paper-unger-trial-participation-barriers-jnci-2019","kind":"paper","name":"Unger: most patients never get the chance to join a cancer trial, and when offered, half say yes","route":"/key-papers/paper-unger-trial-participation-barriers-jnci-2019/"},{"id":"paper-bareche-tnbc-microenvironment-jnci-2020","kind":"paper","name":"Unraveling triple-negative breast cancer tumor microenvironment heterogeneity: towards an optimized treatment approach","route":"/key-papers/paper-bareche-tnbc-microenvironment-jnci-2020/"},{"id":"paper-howlader-us-incidence-breast-subtypes-jnci-2014","kind":"paper","name":"US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status","route":"/key-papers/paper-howlader-us-incidence-breast-subtypes-jnci-2014/"},{"id":"paper-johnson-alternative-medicine-jnci-2018","kind":"paper","name":"Use of alternative medicine for cancer and its impact on survival","route":"/key-papers/paper-johnson-alternative-medicine-jnci-2018/"},{"id":"paper-barton-j-natl-cancer-inst","kind":"paper","name":"Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2","route":"/key-papers/paper-barton-j-natl-cancer-inst/"}],"person":[{"id":"carla-van-gils","kind":"person","name":"Carla van Gils","route":"/people/carla-van-gils/"}]}}